Physician profile
Catherine E Walker
NPI 1255749560
$5,456.18
in general payments reported to CMS, 2019-2025
23 companies · $829 in 2025
The $829 reported for 2025 was more than what 94% of Women'S Health (Nurse Practitioner) providers received nationally (typical 2025 total: $123).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $473 · 2022: $821 · 2023: $1,837 · 2024: $1,496 · 2025: $829.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $4,077 · Education: $84.99.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $4,077.34 |
| Education | $84.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Merck Sharp & Dohme LLC | $1,055.49 | 2021-2025 | Keytruda, Lynparza, Keytruda Qlex |
| Eisai INC. | $1,044.35 | 2022-2025 | |
| Glaxosmithkline, LLC. | $598.69 | 2021-2025 | Jemperli, Zejula |
| Astrazeneca Pharmaceuticals Lp | $571.22 | 2021-2025 | Lynparza, Evusheld |
| Myriad Genetic Laboratories, INC. | $434.87 | 2021-2024 | Myrisk, Precisetumor |
| Abbvie INC. | $427.58 | 2021-2025 | |
| Astellas Pharma US INC | $267.68 | 2023-2025 | Veozah |
| Caris Mpi, INC. | $196.39 | 2025 | Mi Cancer Seek |
| Immunogen, INC. | $195.70 | 2023-2024 | Elahere, Elahere |
| Seagen INC. | $119.07 | 2021-2023 | Tivdak |
| Baxter Healthcare | $71.39 | 2023-2024 | Floseal, Perclot |
| Smith+Nephew, INC. | $65.26 | 2024 | Stravix, Stravix Pl |
| Hologic Sales and Service, LLC | $60.66 | 2021-2023 | Aptima |
| Clovis Oncology, INC. | $54.50 | 2021-2022 | |
| Kyowa Kirin, INC. | $53.48 | 2021 |
Show all 23 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $46.59 | 2024 | Ligasure |
| Cmp Pharma, INC. | $43.14 | 2022 | |
| Cumberland Pharmaceuticals, INC. | $37.57 | 2022-2023 | Sancuso |
| Verastem, INC. | $34.86 | 2025 | Avmapki Fakzynja Co-Pack |
| Lsi Solutions INC | $21.80 | 2023 | Fornisee |
| Daiichi Sankyo INC. | $19.89 | 2024 | Enhertu |
| Mylan Institutional INC. | $18.87 | 2022 | |
| Coherus Oncology, INC. | $17.13 | 2023 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Catherine Walker listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.